Home|About us|Contact us

Bowel and Cancer Research

At Genavco we look to enjoy what we are doing, and are privileged to work in a successful business in an industry sector which provides significant wealth for the UK.

We also believe in giving something back, and our committed and motivated staff raise money for a number of charities, which we as a business also look to support.

As a business we have chosen to support Bowel & Cancer Research, a growing national charity based at the National Centre for Bowel research and Surgical Innovation, Barts and the London School of Medicine and Dentistry.

Digestive diseases are among the most prevalent and distressing health issues but a lack of funding has meant that advances lag behind other areas of disease research. With 41,000 people being diagnosed with bowel cancer annually, more than 250,000 living with inflammatory Bowel Disease – colitis and Crohn’s disease – and upwards of 100,000 people living with a stoma (colostomy), Bowel & Cancer Research is determined to make a difference.

The Charity offers a unique approach to tackling bowel disease. It raised the money for the UK’s first National Centre dedicated to bowel disease research – the National Centre for Bowel Research and Surgical Innovation – it funds first class medical research, generates awareness of bowel cancer and other diseases and support patients and the public to become more closely involved in the research process.

The charity’s support of the National Centre and high quality research around the UK is having major implications for investigations into diseases such as Crohn’s and colitis as well as conditions such as obesity and chronic constipation. In bowel cancer research, among others, it is funding new genetic techniques to see if we can switch off a main gene implicated in bowel cancer development and if aspirin can make current therapies more effective.

Bowel & Cancer Research funding is allocated under two programmes, Saving Lives (bowel cancer) and Changing Lives (chronic bowel disease), more details of which can be found on its website www.bowelcancerresearch.org.